Wertigkeit der Elektromyografie bei Diagnose inflammatorischer Myopathien: Interpretation des EMG – für Rheumatologen

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: ao. Univ.-Prof. Dr. Stefan Quasthoff

Klinische Abteilung für Allgemeine ­Neurologie, Medizinische Universität Graz


Literatur
1 Hilton-Jones D, Observations on the classification of the inflammatory myopathies. Presse Med 2011; 40:199–208
2 Nava A, Orozco-Barocio G, Abordaje en el diagnóstico diferencial de las miopatías inflamatorias. Reumatol Clin 2009; 5(Suppl 3):32–4
3 López Longo FJ, Miopatías inflamatorias. Nuevos conceptos. Reumatol Clin 2008; 4(Suppl 1):40–4
4 Amato AA, Barohn RJ, Evaluation and treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry 2009; 80:1060–8
5 Amato AA, Barohn RJ, Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 2009; 80:1186–93
6 Bohan A et al., Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56:255–86
7 Kyriakides T et al., EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol 2010; 17:767–73
8 Levin R et al., The time course of creatine kinase elevation following concentric needle EMG. Muscle Nerve 1987; 10:242–5
9 Lynch SL et al., Complications of needle electromyography: hematoma risk and correlation with
anticoagulation and antiplatelet therapy. Muscle Nerve 2008; 38:1225–30
10 Boon AJ et al., Hematoma risk after needle EMG. Muscle Nerve 2011; 44:439–40
11 Bautista-Lorite J, Miopatías. En: Gutiérrez-Rivas E et al., Manual de electromiografía clínica. 2a ed. Madrid: Ergón 2008; 355–72
12 Rojas-García R, Díaz Manera J, Illa Sendra I, Análisis de la actividad muscular espontánea. En: Gutiérrez-Rivas E et al., Manual de electromiografía clínica. 2a ed. Madrid: Ergón 2008; 107–17
13 Fernández-Rodríguez JM, Mederer-Hengstl S, Análisis de la actividad muscular voluntaria. En: Gutiérrez-Rivas E et al., Manual de electromiografía clínica. 2a ed. Madrid: Ergón 2008; 119–32
14 Lacomis D, Electrodiagnostic approach to the patient with suspected myopathy. Neurol Clin N Am 2002; 20:587–603
15 Blijham PJ et al., Needle electromyographic findings in 98 patients with myositis. Eur Neurol 2006; 55:183–8
16 Catoggio LJ, Soriano ER, Rosa JE, Tratamiento y pronóstico [de las miopatías inflamatorias]. Reumatol Clin 2009; 5(Suppl 3):35–9
17 Fuglsang-Frederiksen A, The role of different EMG methods in evaluating myopathy. Clin Neurophysiol 2006; 117:1173–89
18 Mastaglia FL, When the treatment does not work: polymyositis. Pract Neurol 2008; 8:170–4
19 Benveniste O, Romero NB, Myositis or dystrophy? Traps and pitfalls. Presse Med 2011; 40:249–55
20 Gutiérrez-Gutiérrez G, Miopatías producidas por tóxicos industriales, animales y vegetales. Rev Neurol 2010; 51:360–6
21 Ayllón-Muñoz JA, Martínez-Costa X, Cano-Orgaz A, Miopatía inducida por colquicina con miotonía asociada. Rev Neurol 2002; 35:195.
22 Kuncl RW et al., Exocytotic „constipation“ is a mechanism of tubulin/lysosomal interaction in colchicine myopathy. Exp Cell Res 2003; 285:196–207
23 Rutkove SB et al., Myotonia in colchicine myoneuropathy. Muscle Nerve 1998; 21:550–1
24 Casado E et al., Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 2006; 65:385–90
25 Abdel-Hamid H, Oddis CV, Lacomis D, Severe hydroxycholoquine myopathy. Muscle Nerve 2008; 38:1206–10
26 Siddiqui AK et al., Hydroxycloroquine-induced toxic myopathy causing respiratory failure. Chest 2007; 131:585–90
27 Myopathy. In: Preston D, Shapiro B (editors), Electromyography and neuromuscular disorders. 2nd ed. Philadelphia: Elsevier 2005; 575–89

FdR 04|2014

Publikationsdatum: 2014-12-23